Your browser doesn't support javascript.
loading
Phase 1 adaptive dose-finding study of neoadjuvant gemcitabine combined with radiation therapy for patients with high-risk extremity and trunk soft tissue sarcoma.
Tseng, William W; Zhou, Shouhao; To, Christina A; Thall, Peter F; Lazar, Alexander J; Pollock, Raphael E; Lin, Patrick P; Cormier, Janice N; Lewis, Valerae O; Feig, Barry W; Hunt, Kelly K; Ballo, Matthew T; Patel, Shreyaskumar; Pisters, Peter W T.
Afiliación
  • Tseng WW; Section of Surgical Oncology, Department of Surgery, Keck School of Medicine, University of Southern California, Los Angeles, California.
  • Zhou S; Sarcoma Program, Hoag Family Cancer Institute and Hoag Memorial Hospital Presbyterian, Newport Beach, California.
  • To CA; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Thall PF; Department of Medical Oncology, Keck School of Medicine, University of Southern California, Los Angeles, California.
  • Lazar AJ; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Pollock RE; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Lin PP; Division of Surgical Oncology, James Comprehensive Cancer Center, Ohio State University, Columbus, Ohio.
  • Cormier JN; Department of Orthopedic Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Lewis VO; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Feig BW; Department of Orthopedic Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Hunt KK; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Ballo MT; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Patel S; Department of Radiation Oncology, University of Tennessee Health Sciences Center, Memphis, Tennessee.
  • Pisters PW; Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Cancer ; 121(20): 3659-67, 2015 Oct 15.
Article en En | MEDLINE | ID: mdl-26177983
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Fármacos Sensibilizantes a Radiaciones / Sarcoma / Desoxicitidina / Extremidades / Torso Tipo de estudio: Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Humans / Middle aged Idioma: En Revista: Cancer Año: 2015 Tipo del documento: Article Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Fármacos Sensibilizantes a Radiaciones / Sarcoma / Desoxicitidina / Extremidades / Torso Tipo de estudio: Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Humans / Middle aged Idioma: En Revista: Cancer Año: 2015 Tipo del documento: Article Pais de publicación: Estados Unidos